Skip to main content
main-content

Diabetes & Endocrinology

An online resource for diabetes professionals

Medicine Matters diabetes is SpringerNature's editorially independent, free to access online resource for healthcare professionals working with diabetes patients. Find the latest news and in-depth articles from medwireNews, read opinions and updates from our clinical advisors, and access a wealth of peer-reviewed research and educational materials.

Diabetes news headlines

Paediatric endocrinology

Interested in paediatric endocrinology?

Visit our dedicated microsite for research news, interviews and in-depth analysis of paediatric endocrinology and growth disorders.

  • rhGH therapy does not impact lifetime IGF-1 exposure in SGA children

  • PEGylated weekly rhGH promising in idiopathic short stature

  • Somatropin safety and efficacy confirmed for childhood growth disorders

Pituitary-targeting seliciclib may warrant further investigation for Cushing’s disease

Two phase 2 studies published in The Journal of Clinical Endocrinology & Metabolism in October 2022 suggest that seliciclib, a selective cyclin-dependent kinase inhibitor targeting pituitary adrenocorticotropic 2 hormone production, may improve hypercortisolemia in patients with Cushing’s disease.

Extension study points to ‘considerable long-term benefits’ of osilodrostat

The LINC 3 extension study, by Maria Fleseriu and team, suggests that long-term treatment with osilodrostat is associated with sustained benefits for people with Cushing’s disease.